Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-18-000042
Filing Date
2018-05-10
Accepted
2018-05-10 16:07:50
Documents
55
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM 10-Q cdtx10-q2018x03.htm 10-Q 813637
2 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit311.htm EX-31.1 9213
3 CERTIFICATION OF CFO PUSRUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit312.htm EX-31.2 9180
4 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit321.htm EX-32.1 6659
5 CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit322.htm EX-32.2 6665
  Complete submission text file 0001610618-18-000042.txt   3574214

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cdtx-20180331.xml EX-101.INS 556228
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20180331.xsd EX-101.SCH 30917
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20180331_cal.xml EX-101.CAL 47139
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20180331_def.xml EX-101.DEF 120333
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20180331_lab.xml EX-101.LAB 443055
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20180331_pre.xml EX-101.PRE 242106
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 18822542
SIC: 2836 Biological Products, (No Diagnostic Substances)